405 filings
6-K
IPCIF
Intellipharmaceutics International Inc.
5 Dec 19
Primary Document
9:36am
6-K
IPCIF
Intellipharmaceutics International Inc.
25 Nov 19
Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc. for Venlafaxine ER
4:39pm
SC 13D/A
IPCIF
Intellipharmaceutics International Inc.
18 Nov 19
Intellipharmaceutics International Inc.
5:03pm
6-K
IPCIF
Intellipharmaceutics International Inc.
18 Nov 19
Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing
4:38pm
6-K
IPCIF
Intellipharmaceutics International Inc.
7 Nov 19
Intellipharmaceutics Announces Settlement Agreement in Class Action Lawsuit, Which is Subject to Court Approval
4:20pm
6-K
a1w g2knox
24 Oct 19
Intellipharmaceutics Update on its Oxycodone ER New Drug Application
1:48pm
6-K
wo482
11 Oct 19
Primary Document
5:20pm
6-K
2yd3k3a cxus4srbv
4 Oct 19
Intellipharmaceutics Announces an Update in the Purdue Litigation
8:07am
6-K
1u6d h88r0gqw
5 Sep 19
Primary Document
1:44pm
6-K
o9ctfo5jcclgwj9u
15 Aug 19
Primary Document
3:28pm
6-K
1i6r5kl301gf
24 Jul 19
Update on its Oxycodone ER New Drug Application
5:13pm
6-K
p1zg5o
10 Jul 19
Primary Document
5:08pm
6-K
yyf94ocr yotxmj
8 Jul 19
Primary Document
5:18pm
25-NSE
l5hqutokmueoina
3 Jun 19
Exchange delisting
9:59am
6-K
zyj1us4ogo
30 May 19
Intellipharmaceutics Announces Receipt of Cannabis Drug License from Health Canada
8:51am
6-K
144yg
29 May 19
Intellipharmaceutics Reports Director Election Results
5:07pm
424B3
sq15 6f69
29 May 19
Prospectus supplement
3:18pm
424B3
5c6siwpul p7cexbca2
29 May 19
Prospectus supplement
3:13pm
6-K
31djb7r7zuj imv87
29 May 19
Intellipharmaceutics to present at the 9th Annual LD Micro Invitational
9:38am
6-K
dj6yoazdmlg
28 May 19
Annual & Special Meeting of Shareholders
4:41pm